Bacteriologia, virusologia, parazitologia, epidemiologia (Bucharest, Romania : 1990)最新文献

For a long period of time, microbiological analysis of samples gathered from individuals, food and environment was based on culture techniques which were considered "gold standard". These conventional methods are yet time-consuming (with respect to germ identification and characterization), cumulative costs are huge, which made research focus on obtaining methods with a rapidity / cost ratio higher than that of classical methods. Rapid diagnostic became as well a priority in the case of food-borne diseases determined by Salmonella spp. These methods of rapid diagnostic are based on phenotypic or molecular techniques for identification and typing, as well as on tests using biosensors and DNA chips, which are under development, and which use the capacity of real-time monitoring of the presence of multiple pathogens in food. With the continuous development of new molecular technologies allowing the rapid detection of food pathogens, the future of conventional microbiological methods looks rather insecure, the more so as there is continuous interest in improving the performances of genotypic methods regarding easy handling, reliability and low costs. The work reviews the panoply of Salmonella identification and typing tests available in the present.

Malaria is the most common disease in the tropical areas and the most common imported disease in the non endemic areas, being considered by WHO a public health issue. About half of the world population lives in zones where there is a malaria risk, and in 2008 were reported 243 million malaria cases and 863.000 deaths. Europe was declared "malaria-free" by WHO in 1975. However there are still cases, most of them imported due to migration and travelling to high risk zones. In 2008 in Europe were reported 5848 imported cases in 25 countries. In recent years there were sporadic indigenous cases in Spain (2009) and Greece (2009, 2011), but the risk of malaria transmission in Europe is considered low in present. In Romania since 1961 indigenous transmission was interrupted, and starting with 1963 we are in the maintenance phase of malaria eradication. in the period 2007-2010 were reported 68 cases of malaria, all imported (24 cases in 2007, 13 cases in 2008, 12 cases in 2009 and 19 cases in 2010) and one death in 2007 (to a man aged 40 years infected in Uganda and who developed a toxic form of malaria with Plasmodium falciparum). Most cases of malaria (94.1%) were recorded in men who have traveled for work in Africa (83.8%), and who were infected with Plasmodium falciparum (67.7% of cases). Occurrence of malaria cases in non endemic areas is possible by the increasing number of people who travel in the risk areas and/ or ignoring and not following prevention measures, respectively chemoprophylaxis and personal protective measures against mosquito's bites.

Yeast biodiversity represents a dynamic scientific domain characterized by permanent emerging theories and accumulation of new data. Identification of genome structure for a number of yeast species and elucidation of regulatory pathways for species-specific metabolic networks, lead to development of numerous applications of yeasts in industry, biotechnology, therapeutics and bioremediation. The studies of the scientific community were long time focused on Saccharomyces cerevisae due mainly to its use in food production. Therefore, the species belonging to Saccharomyces genus became reference points for genomics and biodiversity studies. During last decades there is a growing interest for yeast species able to produce biomass by assimilating or degrading various compounds such as methanol, hydrocarbons, wood hydrolisates and other residues or by-products from different industries.

Unlabelled: Immunocompromised hosts are subjects of predilection to bloodstream infections. The global mortality is high. Bacterial strains are frequently multiresistant; fungemias are almost always deadly, in spite of the susceptibility of the fungus.

Objective: to evaluate the positive blood cultures in patients with malignant and non-malignant diseases and to determine the resistance mechanisms with the Vitek2.

Material and method: a 29 months study--181 episodes of invasive infections--168 patients. The blood culture vials were Bactec Plus. The isolates were identified using Api galleries and with the Vitek 2. The susceptibility was tested by the disk-diffusion method (Oxoid Ltd.). Minimal inhibitory concentrations: Vitek2.

Interpretation: EUCAST 2008 standard.

Results: overall mortality: 27%. Gram-negative bacilli: 59.4% and 48.5% Gram-positive cocci. Klebsiella pneumoniae and Escherichia coli isolates accounted for 16.43% and 71.23%respectively; 25% of E. coli strains and 33% of K. pneumoniae respectively, produced extended-spectrum beta-lactamases. Oxacillin resistance: 54.4% of S. aureus isolates. No resistance to carbapenems in enterobacteria.

Conclusions: Bacterial resistance is not likely to decrease, if at all; Death produced by infections is an event that can be prevented. Molecular determinations should be performed to assess the role of the virulence genes and of the resistance mechanisms and to help the better understanding of the interractions between bacteria and the human organism.

A large distributed bacterium, Listeria monocytogenes has been isolated from water and fresh vegetables, raw meat and processed meat (all types), and raw, salted and smoked fish. L. monocytogenes grows at low oxygen concentrations and at low temperatures, surviving for a long time in the environment, in the processing plant, as well as on the equipment, instruments and during storage at the refrigeration temperature. L. monocytogenes causes invasive listeriosis, often affecting immunocompromised individuals. Epidemiologically, listeriosis appears as sporadic cases and outbreaks, with an incidence of 3-8 cases/1000000 inhabitants, run-down in most countries, reflecting the measures compulsory in food processing industry. The purpose of this review is to describe the measures regarding the implementation of Current Good Manufacturing Practice (CGMP), to protrude the integrity of cold chain through preparing, packing and holding food, including household refrigerating, and to increase a good communication, particularly for consumers at increased risk of listeriosis.

Objective: Antibiotic resistance evaluation of Gram-positive cocci isolated in 2008.

Material and methods: Antibiotic susceptibility testing was performed for 1044 strains: 610 Staphylococcus aureus (352 from patients, 258 from carriers), 203 Streptococcus pneumoniae (53 from patients, 150 from carriers), 144 Enterococcus faecalis. 57 Enterococcus faecium and 30 Streptococcus spp. using automatic systems Vitek 2 Compact. MicroScan, disc diffusion method and Etest according to 2008 CLSI. A number of 497 Streptococcus pyogenes strains were tested for eritromycin resistance.

Results: There were 33.2% MRSA for strains isolated from patients and 30.0% from carriers. From MRSA strains. 35.5% were resistant to gentamicin. 33.6% to ciprofloxacin, 74.3% to erythromycin and 30.5% to rifampin. There were no S. aureus strain resistant to vancomycin and linezolid. S. aureus strains isolated from wounds were more resistant to erythromycin (43.9%) than the strains isolated from systemic infections (12.1%). From 11 S. pneumoniae strains isolated from meningitis, 4 were resistant to penicillin. Neither S. pneumoniae strain isolated from other infections, nor those from carriers had MIC to penicillin more than 4 microg/ml. S. pneumoniae strains isolated from carriers were more resistant to erythromycin. clindamycin and tetracycline than the strains isolated from patients (66.7%, 54.1%, 54.2% vs. 27.4%, 22.6%, 33.9%). E. faecium was 95.9% resistant to penicillin, 90.2% to ampicillin, 64.7% to gentamicin, 72.0% to streptomycin and 78.4% to ciprofloxacin. F. faecalis was less resistant than E. faecium at most of the antibiotics: 32.4% to gentamicin, 59.6% to streptomycin, 28.5% to ciprofloxacin. Viridans group Streptococci, all isolated from blood culture were 92% susceptible to penicillin and ampicillin. To erythromycin, 12% of viridians group Streptococci were resistant. S. pyogenes resistance to eritromycin was 5.8%.

Conclusions: S. aureus strains showed a relatively high level of resistance to oxacillin (33.2%) and resistance in the same time to several antibiotics. S. pneumoniae can not be considered resistant to penicillin administrated parenteral, with exception of the strains isolated from meningitis. E. faecium had a higher resistance rate than E. faecalis.

Aim: Testing antibiotic resistance of bacterial strains (compulsor, reported for EARSS surveillance) isolated from patients hospitalised for systemic infection in the "Dr. V. Babe" Hospital for Infectious and Tropical Diseases during 01.01.2005-11.11.2009, for a dynamic evaluation and for the surveillance of resistance emergence for certain classes of antibiotics.

Material and methods: Bacterial isolation: BacT/ALERT system; strain identification in classic and automated system (ATB Expression. VITEK 2C): antibioresistance: disk-difussion method (NCCLS 2005--CLSI 2009), MIC (E-Test, ATB/ Expression, VITEK 2C). Screening of ESBL-producing strains performed with double disk-difussion method (DDD). Reference strains used: S. aureus ATCC 25923, S. pneumoniae ATCC 49619, E. coli A TCC 25922, Enterococcus fiecalis ATCC 29212.

Results: During the studied period, 245 bacterial strains have been isolated, identified and tested (Staphylococcus aureus / 70, Streptococcus pneumoniae / 61, Enterococcus faecalis / 18, Enterococcus faecium / 5, Neisseria meningitidis / 18, E. coli / 73). out of 166 hemocultures and 79 cerebrospinal fluids / CSF. The average incidence of MRSA strains in systemic infections was 34.28%. 44.28% of the S. aureus strains were resistant to erythromycin, 17.14% to cyprofloxacyne, 15.71% to rifampicine, 14.49% to gentamycine. No strain resistant to vancomycine and linezolide. Streptococcus pneumoniae presented an average high resistance to penicillin G of 11.47%. and a 1.63% resistance to third generation cephalosporines. 0% resistance to vancomycine and rifampicine. 7/ 18 Enterococcus faecalis strains and 4/5 Enterococcus faecium strains presented high level resistance to gentamycine (CN 120 microg/disk) and no strain was resistant to vancomycine, teicoplanin or linezolid. The 18 Neisseria meningitidis strains were all sensitive to beta-lactams, macrolides, fluoroquinolones and cloramphenicol. For the 73 Escherichia coli strains, the average incidence of ESBL-producing isolates was 10.95%, the average resistance to ampicillin was 58.90%, to gentamycine--13.88% and to cyprofloxacin--20.83%. No strain resistant to carbapenemes and amikacine.

Conclusions: For the systematic surveillance of antibiotic resistance there is a need for a harmonised protocol of data gathering and strain selection and the rigurous implementation of correct evaluating methods for antibiotic resistance in the microbiology laboratory. Carbapenemes. glycopeptides and oxazolidinones still present a major effectiveness in the first intention treatment of systemic infections.

One of the major causes leading to increased antibiotic resistance is excess antimicrobial consumption. We have analysed the correlation between antibiotic use and frequency of carbapenem-resistant Pseudomonas aeruginosa (CRPA) strains in the general intensive care unit of a university hospital Antibiotic use was expressed as number DDD (daily defined doses)/100 occupied hospital bed-days (BD). CRPA incidence rates were determined by number of unique isolates reported to 100,000 BD. The average use of antibiotics between January and August 2008 was 174 DDD/100 BD. The first four most frequently prescribed antibiotics were as follows: first and second generation cephalosporins (47 DDD/100 BD), carbapenemns (29 DDD/100 BD), fluoroquinolones (26 DDD/100 BD) and glycopeptids (20 DDD/100 BD). Average monthly incidence rate of CRPA was 546/100,000 BD (319-773/100,000 BD. CI 95%). There was a correlation between CRPA incidence rate and carbapenem plus fluoroquinolone use (Pearson coefficient of correlation r = 0.7, p < 0.05). Our data showed that the evolution of CRPA incidence rates was related to carbapenem and fluoroquinolone use.